Berenice M. Lang

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Current challenges in standardising classification and management of locally advanced cutaneous squamous cell carcinoma.

Current challenges in standardising classification and management of locally advanced cutaneous squamous cell carcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 18, 2026

Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.

Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 03, 2025

Long-term disease control of disseminated superficial actinic porokeratosis (DSAP) with simvastatin 2%/ cholesterol 2% cream.

Long-term disease control of disseminated superficial actinic porokeratosis (DSAP) with simvastatin 2%/ cholesterol 2% cream.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: April 28, 2025

Photoaging and Cosmetic Result with Artificial Daylight Photo-dynamic Therapy Using Methyl Aminolevulinate.

Photoaging and Cosmetic Result with Artificial Daylight Photo-dynamic Therapy Using Methyl Aminolevulinate.

Journal: Acta dermato-venereologica

Published: February 24, 2025

First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG.

First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 24, 2025

Real-world evidence - biosimilars can successfully substitute biologics in psoriasis and hidradenitis suppurativa.

Real-world evidence - biosimilars can successfully substitute biologics in psoriasis and hidradenitis suppurativa.

Journal: Postepy dermatologii i alergologii

Published: January 25, 2025

Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight.

Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight.

Journal: The British journal of dermatology

Published: September 09, 2024

S2k guideline basal cell carcinoma of the skin (update 2023).

S2k guideline basal cell carcinoma of the skin (update 2023).

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: May 29, 2024

Midwives as influencers in skin care for newborns at risk of atopic diseases : Survey of midwives' current recommendations

Midwives as influencers in skin care for newborns at risk of atopic diseases : Survey of midwives' current recommendations

Journal: Dermatologie (Heidelberg, Germany)

Published: March 18, 2024

If patients had a choice - Treatment satisfaction and patients' preference in therapy of actinic keratoses.

If patients had a choice - Treatment satisfaction and patients' preference in therapy of actinic keratoses.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: January 08, 2024

Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product.

Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product.

Journal: Pharmaceutics

Published: December 01, 2022

Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry.

Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry.

Journal: Cancers

Published: October 26, 2022

Showing 1-12 of 44

Last Updated: 09/26/2026